Skip to main content
Top
Gepubliceerd in: Quality of Life Research 1/2011

01-02-2011

Impact and characteristics of quality of life in Japanese patients with multiple sclerosis

Auteurs: Hiromi Kikuchi, Nobuhiro Mifune, Masaaki Niino, Sadayoshi Ohbu, Jun-ichi Kira, Tatsuo Kohriyama, Kohei Ota, Masami Tanaka, Hirofumi Ochi, Shunya Nakane, Masaji Maezawa, Seiji Kikuchi

Gepubliceerd in: Quality of Life Research | Uitgave 1/2011

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

To evaluate health-related quality of life (HRQOL) in Japanese patients with multiple sclerosis (MS) and investigate associations between the results of these QOL assessments and disease severity.

Methods

One-hundred sixty-three Japanese MS patients completed a questionnaire battery comprising the Functional Assessment of MS (FAMS), the Nottingham Adjustment Scale-Japanese version (NAS-J), and the European QOL scale (EQ-5D). Additional five factors affecting QOL as identified by MS patients in a focus group interview were also investigated: employment status, change of income, availability of disease information, communication with medical staff, and care received. Disease severity was determined using the Expanded Disability Status Scale (EDSS).

Results

There was a strong negative correlation of the subscale scores for mobility, symptoms, emotional well-being, thinking and fatigue, and additional concerns on the FAMS with EDSS score. For the NAS-J, only acceptance of the condition was correlated with disease severity. Among the five additional aspects of the condition identified by patients, employment status, income, and disease information were shown to be important for maintaining QOL in patients with MS.

Conclusions

Support for finding employment and having increased or maintained household income and readily available information about the disease contribute to improving QOL in Japanese MS patients.
Literatuur
1.
go back to reference Eldar, R. (2003). Quality of life: An outcome of care measure. The case of multiple sclerosis. Croatian Medical Journal, 44(6), 786–788.PubMed Eldar, R. (2003). Quality of life: An outcome of care measure. The case of multiple sclerosis. Croatian Medical Journal, 44(6), 786–788.PubMed
2.
go back to reference Amato, M. P., Ponziani, G., Rossi, F., Liedl, C. L., Stefanile, C., & Rossi, L. (2001). Quality of life in multiple sclerosis: The impact of depression, fatigue and disability. Multiple Sclerosis, 7(5), 340–344.PubMed Amato, M. P., Ponziani, G., Rossi, F., Liedl, C. L., Stefanile, C., & Rossi, L. (2001). Quality of life in multiple sclerosis: The impact of depression, fatigue and disability. Multiple Sclerosis, 7(5), 340–344.PubMed
3.
go back to reference Visschedijk, M. A., Uitdehaag, B. M., Klein, M., van der Ploeg, E., Collette, E. H., Vleugels, L., et al. (2004). Value of health-related quality of life to predict disability course in multiple sclerosis. Neurology, 63(11), 2046–2050.PubMed Visschedijk, M. A., Uitdehaag, B. M., Klein, M., van der Ploeg, E., Collette, E. H., Vleugels, L., et al. (2004). Value of health-related quality of life to predict disability course in multiple sclerosis. Neurology, 63(11), 2046–2050.PubMed
4.
go back to reference Benedict, R. H., Fishman, I., McClellan, M. M., Bakshi, R., & Weinstock-Guttman, B. (2003). Validity of the beck depression inventory-fast screen in multiple sclerosis. Multiple Sclerosis, 9(4), 393–396.CrossRefPubMed Benedict, R. H., Fishman, I., McClellan, M. M., Bakshi, R., & Weinstock-Guttman, B. (2003). Validity of the beck depression inventory-fast screen in multiple sclerosis. Multiple Sclerosis, 9(4), 393–396.CrossRefPubMed
5.
go back to reference Benedict, R. H., Wahlig, E., Bakshi, R., Fishman, I., Munschauer, F., Zivadinov, R., et al. (2005). Predicting quality of life in multiple sclerosis: Accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. Journal of the Neurological Sciences, 231(1–2), 29–34.CrossRefPubMed Benedict, R. H., Wahlig, E., Bakshi, R., Fishman, I., Munschauer, F., Zivadinov, R., et al. (2005). Predicting quality of life in multiple sclerosis: Accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. Journal of the Neurological Sciences, 231(1–2), 29–34.CrossRefPubMed
6.
go back to reference Lobentanz, I. S., Asenbaum, S., Vass, K., Sauter, C., Klösch, G., Kollegger, H., et al. (2004). Factors influencing quality of life in multiple sclerosis patients: Disability, depressive mood, fatigue and sleep quality. Acta Neurologica Scandinavica, 110(1), 6–13.CrossRefPubMed Lobentanz, I. S., Asenbaum, S., Vass, K., Sauter, C., Klösch, G., Kollegger, H., et al. (2004). Factors influencing quality of life in multiple sclerosis patients: Disability, depressive mood, fatigue and sleep quality. Acta Neurologica Scandinavica, 110(1), 6–13.CrossRefPubMed
7.
go back to reference Goldman Consensus Group. (2005). The Goldman consensus statement on depression in multiple sclerosis. Multiple Sclerosis, 11(3), 328–337.CrossRef Goldman Consensus Group. (2005). The Goldman consensus statement on depression in multiple sclerosis. Multiple Sclerosis, 11(3), 328–337.CrossRef
8.
go back to reference Janardhan, V., & Bakshi, R. (2002). Quality of life in patients with multiple sclerosis: The impact of fatigue and depression. Journal of the Neurological Sciences, 205(1), 51–58.CrossRefPubMed Janardhan, V., & Bakshi, R. (2002). Quality of life in patients with multiple sclerosis: The impact of fatigue and depression. Journal of the Neurological Sciences, 205(1), 51–58.CrossRefPubMed
9.
go back to reference Krupp, L. B., LaRocca, N. G., Muir-Nash, J., & Steinberg, A. D. (1989). The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of Neurology, 46(10), 1121–1123.PubMed Krupp, L. B., LaRocca, N. G., Muir-Nash, J., & Steinberg, A. D. (1989). The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of Neurology, 46(10), 1121–1123.PubMed
10.
go back to reference Schurch, B., Denys, P., Kozma, C. M., Reese, P. R., Slaton, T., & Barron, R. (2007). Reliability and validity of the Incontinence Quality of Life Questionnaire in patients with neurogenic urinary incontinence. Archives of Physical Medicine and Rehabilitation, 88(5), 646–652.CrossRefPubMed Schurch, B., Denys, P., Kozma, C. M., Reese, P. R., Slaton, T., & Barron, R. (2007). Reliability and validity of the Incontinence Quality of Life Questionnaire in patients with neurogenic urinary incontinence. Archives of Physical Medicine and Rehabilitation, 88(5), 646–652.CrossRefPubMed
11.
go back to reference Janardhan, V., & Bakshi, R. (2000). Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis. Archives of Neurology, 57(10), 1485–1491.CrossRefPubMed Janardhan, V., & Bakshi, R. (2000). Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis. Archives of Neurology, 57(10), 1485–1491.CrossRefPubMed
12.
go back to reference Zivadinov, R., Zorzon, M., Tommasi, M. A., Nasuelli, D., Bernardi, M., Monti-Bragadin, L., et al. (2003). A longitudinal study of quality of life and side effects in patients with multiple sclerosis treated with interferon beta-1a. Journal of the Neurological Sciences, 216(1), 113–118.CrossRefPubMed Zivadinov, R., Zorzon, M., Tommasi, M. A., Nasuelli, D., Bernardi, M., Monti-Bragadin, L., et al. (2003). A longitudinal study of quality of life and side effects in patients with multiple sclerosis treated with interferon beta-1a. Journal of the Neurological Sciences, 216(1), 113–118.CrossRefPubMed
13.
go back to reference Rice, G. P., Oger, J., Duquette, P., Francis, G. S., Bélanger, M., Laplante, S., et al. (1999). Treatment with interferon beta-1b improves quality of life in multiple sclerosis. The Canadian Journal of Neurological Sciences, 26(4), 276–282.PubMed Rice, G. P., Oger, J., Duquette, P., Francis, G. S., Bélanger, M., Laplante, S., et al. (1999). Treatment with interferon beta-1b improves quality of life in multiple sclerosis. The Canadian Journal of Neurological Sciences, 26(4), 276–282.PubMed
14.
go back to reference Patti, F., Pozzilli, C., Montanari, E., Pappalardo, A., Piazza, L., Levi, A., et al. (2007). Effects of education level and employment status on HRQoL in early relapsing-remitting multiple sclerosis. Multiple Sclerosis, 13(6), 783–791.CrossRefPubMed Patti, F., Pozzilli, C., Montanari, E., Pappalardo, A., Piazza, L., Levi, A., et al. (2007). Effects of education level and employment status on HRQoL in early relapsing-remitting multiple sclerosis. Multiple Sclerosis, 13(6), 783–791.CrossRefPubMed
15.
go back to reference Khan, F., Pallant, J., & Brand, C. (2007). Caregiver strain and factors associated with caregiver self-efficacy and quality of life in a community cohort with multiple sclerosis. Disability and Rehabilitation, 29(16), 1241–1250.CrossRefPubMed Khan, F., Pallant, J., & Brand, C. (2007). Caregiver strain and factors associated with caregiver self-efficacy and quality of life in a community cohort with multiple sclerosis. Disability and Rehabilitation, 29(16), 1241–1250.CrossRefPubMed
16.
go back to reference Cutajar, R., Ferriani, E., Scandellari, C., Sabattini, L., Trocino, C., Marchello, L. P., et al. (2000). Cognitive function and quality of life in multiple sclerosis patients. Journal of Neurovirology, 6(Suppl 2), S186–S190.PubMed Cutajar, R., Ferriani, E., Scandellari, C., Sabattini, L., Trocino, C., Marchello, L. P., et al. (2000). Cognitive function and quality of life in multiple sclerosis patients. Journal of Neurovirology, 6(Suppl 2), S186–S190.PubMed
17.
go back to reference Benito-León, J., Morales, J. M., & Rivera-Navarro, J. (2002). Health-related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis patients. European Journal of Neurology, 9(5), 497–502.CrossRefPubMed Benito-León, J., Morales, J. M., & Rivera-Navarro, J. (2002). Health-related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis patients. European Journal of Neurology, 9(5), 497–502.CrossRefPubMed
18.
go back to reference Brown, T. R., & Kreft, G. H. (2005). Exercise and rehabilitation for individual with multiple sclerosis. Physical Medicine and Rehabilitation Clinics of North America, 16(2), 513–555.CrossRefPubMed Brown, T. R., & Kreft, G. H. (2005). Exercise and rehabilitation for individual with multiple sclerosis. Physical Medicine and Rehabilitation Clinics of North America, 16(2), 513–555.CrossRefPubMed
19.
go back to reference Mitchell, A. J., Benito-León, J., González, J. M., & Rivera-Navarro, J. (2005). Quality of life and its assessment in multiple sclerosis: Integrating physical and psychological components of wellbeing. Lancet Neurology, 4(9), 556–566.CrossRefPubMed Mitchell, A. J., Benito-León, J., González, J. M., & Rivera-Navarro, J. (2005). Quality of life and its assessment in multiple sclerosis: Integrating physical and psychological components of wellbeing. Lancet Neurology, 4(9), 556–566.CrossRefPubMed
20.
go back to reference Miller, D. M., Rudick, R. A., Baier, M., Cutter, G., Doughtery, D. S., Weinstock-Guttman, B., et al. (2003). Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis, 9(1), 1–5.CrossRefPubMed Miller, D. M., Rudick, R. A., Baier, M., Cutter, G., Doughtery, D. S., Weinstock-Guttman, B., et al. (2003). Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis, 9(1), 1–5.CrossRefPubMed
21.
go back to reference Vickrey, B. G., Hays, R. D., Harooni, R., Myers, L. W., & Ellison, G. W. (1995). A health-related quality of life measure for multiple sclerosis. Quality of Life Research, 4(3), 187–206.CrossRefPubMed Vickrey, B. G., Hays, R. D., Harooni, R., Myers, L. W., & Ellison, G. W. (1995). A health-related quality of life measure for multiple sclerosis. Quality of Life Research, 4(3), 187–206.CrossRefPubMed
22.
go back to reference Rudick, R. A., Miller, D., Clough, J. D., Gragg, L. A., & Farmer, R. G. (1992). Quality of life in multiple sclerosis. Comparison with inflammatory bowel disease and rheumatoid arthritis. Archives of Neurology, 49(12), 1237–1242.PubMed Rudick, R. A., Miller, D., Clough, J. D., Gragg, L. A., & Farmer, R. G. (1992). Quality of life in multiple sclerosis. Comparison with inflammatory bowel disease and rheumatoid arthritis. Archives of Neurology, 49(12), 1237–1242.PubMed
23.
go back to reference Nortvedt, M. W., & Riise, T. (2003). The use of quality of life measures in multiple sclerosis research. Multiple Sclerosis, 9(1), 63–72.CrossRefPubMed Nortvedt, M. W., & Riise, T. (2003). The use of quality of life measures in multiple sclerosis research. Multiple Sclerosis, 9(1), 63–72.CrossRefPubMed
24.
go back to reference Fischer, J. S., LaRocca, N. G., Miller, D. M., Ritvo, P. G., Andrews, H., & Paty, D. (1999). Recent developments in the assessment of quality of life in multiple sclerosis (MS). Multiple Sclerosis, 5(4), 251–259.PubMed Fischer, J. S., LaRocca, N. G., Miller, D. M., Ritvo, P. G., Andrews, H., & Paty, D. (1999). Recent developments in the assessment of quality of life in multiple sclerosis (MS). Multiple Sclerosis, 5(4), 251–259.PubMed
25.
go back to reference Gold, S. M., Heesen, C., Schulz, H., Guder, U., Mönch, A., Gbadamosi, J., et al. (2001). Disease specific quality of life instruments in multiple sclerosis: Validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS). Multiple Sclerosis, 7(2), 119–130.PubMed Gold, S. M., Heesen, C., Schulz, H., Guder, U., Mönch, A., Gbadamosi, J., et al. (2001). Disease specific quality of life instruments in multiple sclerosis: Validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS). Multiple Sclerosis, 7(2), 119–130.PubMed
26.
go back to reference Hobart, J., Lamping, D., Fitzpatrick, R., Riazi, A., & Thompson, A. (2001). The Multiple Sclerosis Impact Scale (MSIS-29): A new patient-based outcome measure. Brain, 124(5), 962–973.CrossRefPubMed Hobart, J., Lamping, D., Fitzpatrick, R., Riazi, A., & Thompson, A. (2001). The Multiple Sclerosis Impact Scale (MSIS-29): A new patient-based outcome measure. Brain, 124(5), 962–973.CrossRefPubMed
27.
go back to reference Kohmoto, J., Ohbu, S., Nagaoka, M., Suzukamo, Y., Kihira, T., Mizuno, Y., et al. (2003). Validation of the Japanese version of the Parkinson’s Disease Questionnaire. Clinical Neurology, 43(3), 71–76. (Article in Japanese).PubMed Kohmoto, J., Ohbu, S., Nagaoka, M., Suzukamo, Y., Kihira, T., Mizuno, Y., et al. (2003). Validation of the Japanese version of the Parkinson’s Disease Questionnaire. Clinical Neurology, 43(3), 71–76. (Article in Japanese).PubMed
28.
go back to reference Yamaguchi, T., Ohbu, S., Saito, M., Ito, Y., Moriwaka, F., Tashiro, K., et al. (2004). Validity and clinical applicability of the Japanese version of amyotrophic lateral sclerosis—Assessment Questionnaire 40 (ALSAQ-40). No To Shinkei, 56(6), 483–494. (Article in Japanese).PubMed Yamaguchi, T., Ohbu, S., Saito, M., Ito, Y., Moriwaka, F., Tashiro, K., et al. (2004). Validity and clinical applicability of the Japanese version of amyotrophic lateral sclerosis—Assessment Questionnaire 40 (ALSAQ-40). No To Shinkei, 56(6), 483–494. (Article in Japanese).PubMed
29.
go back to reference Cella, D. F., Dineen, K., Arnason, B., Reder, A., Webster, K. A., Karabatsos, G., et al. (1996). Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology, 47(1), 129–139.PubMed Cella, D. F., Dineen, K., Arnason, B., Reder, A., Webster, K. A., Karabatsos, G., et al. (1996). Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology, 47(1), 129–139.PubMed
30.
go back to reference de Sa, J., Fukaura, H., Campos, H., Miller, A., Eremenco, S., Kaskel, P., et al. (2003). Functional Assessment of Multiple Sclerosis (FAMS): Evaluating the linguistic validity and testing results for Portuguese, Japanese and Hebrew speaking patients with MS. Multiple Sclerosis, 9(Suppl 1), S148. de Sa, J., Fukaura, H., Campos, H., Miller, A., Eremenco, S., Kaskel, P., et al. (2003). Functional Assessment of Multiple Sclerosis (FAMS): Evaluating the linguistic validity and testing results for Portuguese, Japanese and Hebrew speaking patients with MS. Multiple Sclerosis, 9(Suppl 1), S148.
31.
go back to reference Kikuchi, H., Kikuchi, S., Ohbu, S., Suzuki, N., & Maezawa, M. (2007). A survey on constitutive element of quality of life with multiple sclerosis. Brain and Nerve, 59(6), 617–622. (Article in Japanese).PubMed Kikuchi, H., Kikuchi, S., Ohbu, S., Suzuki, N., & Maezawa, M. (2007). A survey on constitutive element of quality of life with multiple sclerosis. Brain and Nerve, 59(6), 617–622. (Article in Japanese).PubMed
32.
go back to reference Dadds, A. G., Flannigan, H., & Ng, L. (1993). The Nottingham Adjustment Scale: A validation study. International Journal of Rehabilitation Research, 16(3), 177–184.CrossRef Dadds, A. G., Flannigan, H., & Ng, L. (1993). The Nottingham Adjustment Scale: A validation study. International Journal of Rehabilitation Research, 16(3), 177–184.CrossRef
33.
go back to reference Suzukamo, Y., Kumano, H., & Iwaya, T. (2001). Development and validation of “The Nottingham Adjustment Scale Japanese Version” which measures psychological adjustment to the visual impairment. Japanese Journal of Psychosomatic Medicine, 41(8), 609–618. (Article in Japanese). Suzukamo, Y., Kumano, H., & Iwaya, T. (2001). Development and validation of “The Nottingham Adjustment Scale Japanese Version” which measures psychological adjustment to the visual impairment. Japanese Journal of Psychosomatic Medicine, 41(8), 609–618. (Article in Japanese).
34.
go back to reference Suzukamo, Y., Ohbu, S., Kondo, T., Kohmoto, J., & Fukuhara, S. (2006). Psychological adjustment has a greater effect on health-related quality of life than on severity of disease in Parkinson’s disease. Movement Disorders, 21(6), 761–766.CrossRefPubMed Suzukamo, Y., Ohbu, S., Kondo, T., Kohmoto, J., & Fukuhara, S. (2006). Psychological adjustment has a greater effect on health-related quality of life than on severity of disease in Parkinson’s disease. Movement Disorders, 21(6), 761–766.CrossRefPubMed
35.
go back to reference Tsuchiya, A., Ikeda, S., Ikegami, N., Nishimura, S., Sakai, I., Fukuda, T., et al. (2002). Estimating an EQ-5D population value set: The case of Japan. Health Economics, 11(4), 341–353.CrossRefPubMed Tsuchiya, A., Ikeda, S., Ikegami, N., Nishimura, S., Sakai, I., Fukuda, T., et al. (2002). Estimating an EQ-5D population value set: The case of Japan. Health Economics, 11(4), 341–353.CrossRefPubMed
36.
go back to reference Schumacker, G. A., Beebe, G. W., Kibler, R. F., Kurland, L. T., Kurtzke, J. F., Mcdowell, F., et al. (1965). Problems of experimental trials of therapy in multiple sclerosis. Annals of New York Academy of Sciences, 122, 552–568.CrossRef Schumacker, G. A., Beebe, G. W., Kibler, R. F., Kurland, L. T., Kurtzke, J. F., Mcdowell, F., et al. (1965). Problems of experimental trials of therapy in multiple sclerosis. Annals of New York Academy of Sciences, 122, 552–568.CrossRef
37.
go back to reference McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H. P., Lublin, F. D., et al. (2001). Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Annals of Neurology, 50(1), 121–127.CrossRefPubMed McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H. P., Lublin, F. D., et al. (2001). Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Annals of Neurology, 50(1), 121–127.CrossRefPubMed
38.
go back to reference Osoegawa, M., Kira, J., Fukazawa, T., Fujihara, K., Kikuchi, S., Matsui, M., et al. (2009). Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: Nationwide survey result over 30 years. Multiple Sclerosis, 15(2), 159–173.CrossRefPubMed Osoegawa, M., Kira, J., Fukazawa, T., Fujihara, K., Kikuchi, S., Matsui, M., et al. (2009). Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: Nationwide survey result over 30 years. Multiple Sclerosis, 15(2), 159–173.CrossRefPubMed
39.
go back to reference Ishizu, T., Kira, J., Osoegawa, M., Fukazawa, T., Kikuchi, S., Fujihara, K., et al. (2009). Heterogeneity and continuum of multiple sclerosis of the forth nationwide survey. Journal of the Neurological Sciences, 280(1–2), 22–28.CrossRefPubMed Ishizu, T., Kira, J., Osoegawa, M., Fukazawa, T., Kikuchi, S., Fujihara, K., et al. (2009). Heterogeneity and continuum of multiple sclerosis of the forth nationwide survey. Journal of the Neurological Sciences, 280(1–2), 22–28.CrossRefPubMed
40.
go back to reference Kurtzke, J. F. (1983). Rating neurological impairment in multiple sclerosis, an Expanded Disability Status Scale (EDSS). Neurology, 33(11), 1444–1452.PubMed Kurtzke, J. F. (1983). Rating neurological impairment in multiple sclerosis, an Expanded Disability Status Scale (EDSS). Neurology, 33(11), 1444–1452.PubMed
41.
go back to reference Patti, F., Russo, P., Pappalardo, A., Macchia, F., Civalleri, L., Paolillo, A., et al. (2007). Predictors of quality of life among patients with multiple sclerosis: An Italian cross-sectional study. Journal of the Neurological Sciences, 252(2), 121–129.CrossRefPubMed Patti, F., Russo, P., Pappalardo, A., Macchia, F., Civalleri, L., Paolillo, A., et al. (2007). Predictors of quality of life among patients with multiple sclerosis: An Italian cross-sectional study. Journal of the Neurological Sciences, 252(2), 121–129.CrossRefPubMed
42.
go back to reference Chang, C. H., Cella, D., Fernández, O., Luque, G., de Castro, P., de Andrés, C., et al. (2002). Quality of life in multiple sclerosis patients in Spain. Multiple Sclerosis, 8(6), 527–531.CrossRefPubMed Chang, C. H., Cella, D., Fernández, O., Luque, G., de Castro, P., de Andrés, C., et al. (2002). Quality of life in multiple sclerosis patients in Spain. Multiple Sclerosis, 8(6), 527–531.CrossRefPubMed
43.
go back to reference Miller, A., & Dishon, S. (2006). Health-related quality of life in multiple sclerosis: The impact of disability, gender and employment status. Quality of Life Research, 15(2), 259–271.CrossRefPubMed Miller, A., & Dishon, S. (2006). Health-related quality of life in multiple sclerosis: The impact of disability, gender and employment status. Quality of Life Research, 15(2), 259–271.CrossRefPubMed
44.
go back to reference Gulick, E. E. (1997). Correlates of quality of life among persons with multiple sclerosis. Nursing Research, 46(6), 305–311.CrossRefPubMed Gulick, E. E. (1997). Correlates of quality of life among persons with multiple sclerosis. Nursing Research, 46(6), 305–311.CrossRefPubMed
45.
go back to reference Somerset, M., Peters, T. J., Sharp, D. J., & Campbell, R. (2003). Factors that contribute to quality of life outcomes prioritized by people with multiple sclerosis. Quality of Life Research, 12(1), 21–29.CrossRefPubMed Somerset, M., Peters, T. J., Sharp, D. J., & Campbell, R. (2003). Factors that contribute to quality of life outcomes prioritized by people with multiple sclerosis. Quality of Life Research, 12(1), 21–29.CrossRefPubMed
46.
go back to reference McCabe, M. P., & Mckern, S. (2002). Quality of life and multiple sclerosis: Comparison between people with multiple sclerosis and people from the general population. Journal of Clinical Psychology in Medical Settings, 9(4), 287–295.CrossRef McCabe, M. P., & Mckern, S. (2002). Quality of life and multiple sclerosis: Comparison between people with multiple sclerosis and people from the general population. Journal of Clinical Psychology in Medical Settings, 9(4), 287–295.CrossRef
47.
go back to reference Janssens, A. C., van Doorn, P. A., de Boer, J. B., Kalkers, N. F., van der Meche, F. G., Passchier, J., et al. (2003). Anxiety and depression influence the relation between disability status and quality of life in multiple sclerosis. Multiple Sclerosis, 9(4), 397–403.CrossRefPubMed Janssens, A. C., van Doorn, P. A., de Boer, J. B., Kalkers, N. F., van der Meche, F. G., Passchier, J., et al. (2003). Anxiety and depression influence the relation between disability status and quality of life in multiple sclerosis. Multiple Sclerosis, 9(4), 397–403.CrossRefPubMed
48.
go back to reference van Kessel, K., Moss-Morris, R., Willoughby, E., Chalder, T., Johnson, M. H., & Robinson, E. (2008). A randomized controlled trial of cognitive behavior therapy for multiple sclerosis fatigue. Psychosomatic Medicine, 70(2), 205–213.CrossRefPubMed van Kessel, K., Moss-Morris, R., Willoughby, E., Chalder, T., Johnson, M. H., & Robinson, E. (2008). A randomized controlled trial of cognitive behavior therapy for multiple sclerosis fatigue. Psychosomatic Medicine, 70(2), 205–213.CrossRefPubMed
49.
go back to reference Mohr, D. C., Boudewyn, A. C., Goodkin, D. E., Bostrom, A., & Epstein, L. (2001). Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. Journal of Consulting and Clinical Psychology, 69(6), 942–949.CrossRefPubMed Mohr, D. C., Boudewyn, A. C., Goodkin, D. E., Bostrom, A., & Epstein, L. (2001). Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. Journal of Consulting and Clinical Psychology, 69(6), 942–949.CrossRefPubMed
50.
go back to reference Hart, S., Fonareva, I., Merluzzi, N., & Mohr, D. C. (2005). Treatment for depression and its relationship to improvement in quality of life and psychological well-being in multiple sclerosis patients. Quality of Life Research, 14(3), 695–703.CrossRefPubMed Hart, S., Fonareva, I., Merluzzi, N., & Mohr, D. C. (2005). Treatment for depression and its relationship to improvement in quality of life and psychological well-being in multiple sclerosis patients. Quality of Life Research, 14(3), 695–703.CrossRefPubMed
Metagegevens
Titel
Impact and characteristics of quality of life in Japanese patients with multiple sclerosis
Auteurs
Hiromi Kikuchi
Nobuhiro Mifune
Masaaki Niino
Sadayoshi Ohbu
Jun-ichi Kira
Tatsuo Kohriyama
Kohei Ota
Masami Tanaka
Hirofumi Ochi
Shunya Nakane
Masaji Maezawa
Seiji Kikuchi
Publicatiedatum
01-02-2011
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 1/2011
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-010-9725-2

Andere artikelen Uitgave 1/2011

Quality of Life Research 1/2011 Naar de uitgave